Regulation of Gene Expression During Stress

应激期间基因表达的调节

• 批准号: 7900752
• 负责人: MARIA HATZOGLOU
• 金额: $ 10万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7900752
• 关键词: 3' Untranslated Regions; Abbreviations; Ablation; Affect; Amino Acid Sequence; Amino Acid Transporter; Amino Acids; Animal Model; Apoptosis; Arts; Attenuated; Bacterial Artificial Chromosomes; Binding Proteins; Boxing; CCAAT-Enhancer-Binding Proteins; Cationic Amino Acid Transporter 1; Cell Death; Cell Line; Cell Nucleus; Cell physiology; Cells; Cellular Stress; Cellular Stress Response; Cessation of life; Cultured Cells; Diabetes Mellitus; Dimerization; Disease; Embryo; Endoplasmic Reticulum; Endoplasmic Reticulum Degradation Pathway; Equilibrium; Eukaryotic Initiation Factors; Felis catus; Fibroblasts; Firefly Luciferases; Future; GADD45; Gene Expression; Gene Expression Regulation; Gene Targeting; Genes; Genetic Transcription; Glutamic Acid; Goals; Grant; Homologous Gene; Insulin; Internal Ribosome Entry Site; Knock-in Mouse; Liver; Mediating; Membrane; Messenger RNA; Metabolism; Microarray Analysis; Modeling; Molecular; Mus; Mutation; N-terminal; Nerve Degeneration; Nutrient; Obesity; Open Reading Frames; Organelles; Pancreas; Pathology; Pathway interactions; Pharmaceutical Preparations; Phase; Phosphorylation; Phosphotransferases; Physiological; Play; Post-Translational Protein Processing; Prokaryotic Initiation Factor-2; Proline; Protein Biosynthesis; Protein Family; Proteins; Recovery; Regulation; Response Elements; Ribosomes; Role; Serine; Signal Pathway; Starvation; Stress; System; TNF gene; Testing; Thapsigargin; Threonine; Time; Trans-Activators; Transcription Coactivator; Transgenic Mice; Translating; Translations; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors; Ubiquitin; Untranslated Regions; activated Protein C; arginyllysine; biological adaptation to stress; cancer complication; driving force; endoplasmic reticulum stress; enhanced green fluorescent protein; factor C; human disease; interest; liver function; mRNA Decay; mouse model; multicatalytic endopeptidase complex; new therapeutic target; novel; overexpression; programs; protein degradation; research study; response; secretory protein; tool; transcription factor

DESCRIPTION (provided by applicant): In disease states, unfolded proteins accumulate in the endoplasmic reticulum because the folding capacity is exceeded, initiating a cellular stress response (the unfolded protein response or UPR). Our long-term interest is to understand the molecular mechanisms that allow cells to withstand stress and that contribute to pathologies during prolonged stress. Regulation of gene expression by transcriptional activators and repressors is a key feature of the stress response. During the previous grant period we found that the adaptive response to nutrient starvation increases expression of amino acid transporter genes, which can facilitate the recovery from stress. We also found that transcription of the arginine/lysine transporter gene, Cat-1, and of other genes involved in amino acid metabolism is attenuated during prolonged ER stress, mediated by the CCAAT/enhancer binding protein family transcription factor, C/EBP2. Regulated translation of the C/EBP2 mRNA produces both LAP, a transcriptional activator, and LIP a repressor. The LAP/LIP ratio plays a critical role in cell fate and metabolism. We found that the LAP/LIP ratios change during the UPR via mechanisms that involve proteasomal degradation of the proteins and translational control of the C/EBP2 mRNA; this provides the driving force behind this proposal. The regulation of transcription factor levels during ER stress via the proteasome pathway is a novel mechanism to modulate the cellular stress response. We hypothesize that the LAP/LIP ratio plays a role in controlling transcription of stress-response genes. We also hypothesize that the regulation of LIP levels promotes expression of prosurvival genes early in the stress response and restricts expression of proapoptotic genes during prolonged stress. In this proposal, we will study the mechanisms that regulate LIP synthesis and degradation during ER stress in cultured cells and in mice. Experiments using stress-inducing drugs and models of human disease will reveal the physiological significance of this regulation. Our Specific Aims are: (i) Determine the mechanism for diminished LIP levels during the early (prosurvival) phase of ER stress (ii) Investigate the signaling pathways that regulate proteasome-mediated degradation of LIP during the prosurvival phase of ER stress. (iii) Determine the mechanisms that increase LIP levels during the late (proapoptotic) phase of ER stress. (iv) Determine the physiological significance of the LAP/LIP ratio during ER stress using MEFs defficient in C/EBP2 (v) Determine the effect of disruption of the C/EBP2 gene in animal models of ER stress-mediated disease. Our long term goal is to generate transgenic mice expressing only LAP and only LIP by knock-in mutations in the C/EBP2 gene, using the state of the art system of Bacterial Artificial Chromosomes. The knock-in mice will be a valuable tool to determining the functions of LAP and LIP in ER- stress mediated apoptosis and enable us to test the findings of Aims 1-5 in a physiological context with relevance to human disease. Cellular stress is important in a large number of diseases, such as diabetes, neurodegeneration, cancer and complications of obesity. A common feature of these diseases is the accumulation of damaged secretory proteins in the endoplasmic reticulum (ER), a vital organelle responsible for proper cellular function and metabolism. During the previous grant period we found that the adaptive response to nutrient starvation increases expression of amino acid transporter genes, which can facilitate the recovery from stress. PROJECT HEALTH RELEVANCE: This proposal will study C/EBP2, an important regulator of the stress response and how this regulator controls the balance between cellular survival and death. Our studies will generate new therapeutic targets for the many stress-mediated diseases and provide a novel mechanism that regulates the balance between survival and death during these diseases.

描述（由申请人提供）：在疾病状态下，未折叠蛋白在内质网中积累，因为折叠能力被超过，启动细胞应激反应（未折叠蛋白反应或UPR）。我们的长期兴趣是了解允许细胞承受压力的分子机制，以及在长期压力下导致病理的分子机制。通过转录激活因子和抑制因子调控基因表达是应激反应的关键特征。在之前的资助期间，我们发现营养饥饿的适应性反应增加了氨基酸转运蛋白基因的表达，这有助于从逆境中恢复。我们还发现精氨酸/赖氨酸转运蛋白基因Cat-1和其他参与氨基酸代谢的基因的转录在长时间内质网应激下被减弱，这是由CCAAT/增强子结合蛋白家族转录因子C/EBP2介导的。C/EBP2 mRNA受调控的翻译产生转录激活因子LAP和转录抑制因子LIP。LAP/LIP比值在细胞命运和代谢中起关键作用。我们发现LAP/LIP比率在UPR期间通过涉及蛋白质的蛋白酶体降解和C/EBP2 mRNA的翻译控制的机制发生变化；这是这一提议背后的推动力。内质网应激过程中通过蛋白酶体途径调控转录因子水平是调控细胞应激反应的一种新机制。我们假设LAP/LIP比值在控制应激反应基因的转录中起作用。我们还假设LIP水平的调节在应激反应早期促进促生存基因的表达，并在长期应激过程中限制促凋亡基因的表达。在本研究中，我们将在培养细胞和小鼠中研究内质网应激下LIP合成和降解的调控机制。使用应激诱导药物和人类疾病模型的实验将揭示这种调节的生理意义。我们的具体目标是：(i)确定内质网应激早期（促生存）阶段LIP水平降低的机制；（ii）研究内质网应激促生存阶段调节蛋白酶体介导的LIP降解的信号通路。（iii）确定内质网应激后期（促凋亡）阶段LIP水平升高的机制。（iv）利用缺乏C/EBP2的MEFs确定内质网应激期间LAP/LIP比值的生理意义(v)确定C/EBP2基因破坏对内质网应激介导疾病动物模型的影响。我们的长期目标是利用最先进的细菌人工染色体系统，通过敲入C/EBP2基因突变，产生只表达LAP和LIP的转基因小鼠。敲入小鼠将成为确定LAP和LIP在内质网应激介导的细胞凋亡中的功能的有价值的工具，并使我们能够在与人类疾病相关的生理背景下测试Aims 1-5的发现。细胞应激在许多疾病中都很重要，如糖尿病、神经变性、癌症和肥胖并发症。这些疾病的一个共同特征是内质网（ER）中受损分泌蛋白的积累，内质网是负责正常细胞功能和代谢的重要细胞器。在之前的资助期间，我们发现营养饥饿的适应性反应增加了氨基酸转运蛋白基因的表达，这有助于从逆境中恢复。项目健康相关性：本提案将研究应激反应的重要调节因子C/EBP2，以及该调节因子如何控制细胞生存与死亡之间的平衡。我们的研究将为许多应激性疾病提供新的治疗靶点，并提供一种调节这些疾病中生存与死亡平衡的新机制。